Also known as: Sofigatran; TGN255
Sofigatran is a direct thrombin inhibitor developed for anticoagulation therapy. It acts by selectively inhibiting thrombin activity to prevent blood clotting in thromboembolic disorders. Mediocon Inc manufactures GMP-compliant Sofigatran API at its Aurangabad facility to international pharmacopoeial standards.
| Parameter | Specification |
|---|---|
| CAS Number | 187602-11-5 |
| Molecular Formula | C₂₅H₂₄N₄O₅ |
| Molecular Weight | 476.49 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Anticoagulant / Direct Thrombin Inhibitor |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | SG/25030249 |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |